Albemarle Corporation

Albemarle's valuation remains opaque with no meaningful P/E ratio, suggesting either depressed earnings or losses that obscure traditional valuation metrics—unusual for a $20.5B market-cap chemical player. The RSI at 54.2 indicates neither oversold nor overbought conditions, though the vanishingly small 0.04% short float eliminates squeeze concerns and suggests limited bearish conviction. Trading well below its 52-week high, the stock appears caught between lithium market skepticism and structural demand uncertainty, leaving fundamental clarity essential before positioning.